Health care bill
NEW YORK - Drug and hospital companies led stocks higher Monday after House lawmakers ended months of uncertainty and approved the health care overhaul bill.
WASHINGTON - When historians write the book on how President Barack Obama's health care overhaul became law, they'll need to leave space for some unlikely advocates: lobbyists for the drug, insurance and hospital industries.
WASHINGTON - Drug and device maker Abbott Laboratories spent $1.9 million lobbying on health care issues in the fourth quarter of last year, according to a recent disclosure report.
